financetom
Business
financetom
/
Business
/
GE Vernova Q3 Earnings: Strong Sales, Earnings Miss, Cash Flow Surge & More
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GE Vernova Q3 Earnings: Strong Sales, Earnings Miss, Cash Flow Surge & More
Oct 23, 2024 5:26 AM

GE Vernova Inc. ( GEV ) shares are trading lower in premarket after the company reported mixed third-quarter results.

The company reported revenue growth of 8% year-over-year to $8.913 billion and +10% YoY organically, beating the consensus of $8.783 billion.

“GE Vernova had a solid third quarter, delivering double-digit orders and continued revenue growth with services strength across all segments, significant margin expansion in Power and Electrification, and substantial cash generation,” commented GE Vernova ( GEV ) CEO Scott Strazik.

Orders totaling $9.4 billion increased 17% organically, driven by services growth of +28 % organically, with strength across all segments, and equipment growth in Power and Electrification.

Loss per share for the quarter stood at $0.35, compared to a $0.62 loss a year ago, missing the EPS consensus of $0.32. Net loss narrowed to $99 million from $185 million loss last year.

Adjusted EBITDA margin expanded by 20 bps to 2.7% and contracted 70 bps to 2.6% on an organic basis, with Adjusted EBITDA of $243 million (+18.5% YoY).

Power revenue was $4.206 billion (+8% YoY), and Orders reached $5.202 billion (+28% YoY), led by Gas Power equipment and services, with 9 HA and 15 aeroderivative units, and services growth of 29% organically.

Wind revenue was $2.89 billion (flat YoY), and Orders reached $1.747 billion (-19% YoY), reflecting lower Onshore Wind equipment orders outside of North America.

Electrification revenue was $1.928 billion (+22% YoY), driven by Grid Solutions and Power Conversion. Orders gained 17% YoY to $2.51 billion.

Cash from operating activities for the quarter totaled $1.127 billion, compared to $233 million used a year ago. Free cash flow stood at $968 million.

At the end of the quarter, GEV had a $7.4 billion cash balance, up from $5.8 billion in the second quarter of 2024.

Also Read: GE Vernova Vs. GE Healthcare: Betting On Power Or Medical Tech To Lead AI-Powered Future?

2024 Guidance, reaffirmed: GE Vernova ( GEV ) expects revenue to trend towards the higher end of $34 billion – $35 billion versus $34.93 billion.

The company now expects free cash flow to trend towards the higher end of the $1.3 billion – $1.7 billion range.

Price Action: GEV shares traded lower by 4.49% at $264.00 premarket at the last check Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved